View in EDS HTML Full Text PDF Full Text

VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML.

Saved in:
Bibliographic Details
Title: VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML.
Authors: Kretschmer, Lydia1 (AUTHOR) lydia.kretschmer@ukdd.de, Ruhnke, Leo1 (AUTHOR), Schliemann, Christoph2 (AUTHOR), Fransecky, Lars3 (AUTHOR), Steffen, Björn4 (AUTHOR), Kaufmann, Martin5 (AUTHOR), Burchert, Andreas6 (AUTHOR), Schmid, Christoph7 (AUTHOR), Hanoun, Maher8 (AUTHOR), Sauer, Tim9 (AUTHOR), Metzeler, Klaus H.10 (AUTHOR), Schäfer-Eckart, Kerstin11 (AUTHOR), Hänel, Mathias12 (AUTHOR), Crysandt, Martina13 (AUTHOR), Jäger, Paul14 (AUTHOR), Krause, Stefan W.15 (AUTHOR), Dierks, Christine16 (AUTHOR), Klein, Stefan17 (AUTHOR), Maguire, Nadia18 (AUTHOR), Frenzel, Lukas P.19 (AUTHOR)
Source: Annals of Hematology. Jul2025, Vol. 104 Issue 7, p3647-3654. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09395555
DOI:10.1007/s00277-025-06496-7